[Intraocular penetration of several medications with a therapeutic effect on toxoplasmosis. Preliminary study].
D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology* / Q000627:therapeutic use; D002981:Clindamycin / Q000494:pharmacology; D004338:Drug Combinations; D005123:Eye / Q000187:drug effects*; D005260:Female; D006801:Humans; D007933:Leucomycins / Q000494:pharmacology; D008297:Male; D010539:Permeability; D011817:Rabbits; D013420:Sulfamethoxazole / Q000494:pharmacology; D014126:Toxoplasmosis, Ocular / Q000188:drug therapy*; D014295:Trimethoprim / Q000494:pharmacology
D000900:Anti-Bacterial Agents; D004338:Drug Combinations; D007933:Leucomycins; D002981:Clindamycin; D014295:Trimethoprim; D013420:Sulfamethoxazole
Etude de la pénétration intra-oculaire de divers médicaments à effet thérapeutique sur la toxoplasmose. Etude préliminaire.